¸´·½Ðþ¾Ô½ºÄÒÁªºÏ»¯Ñ§Ò©¶Ô±Èµ¥Óû¯Ñ§Ò©ÖÎÁƶàÄÒÂѳ²×ÛºÏÕ÷ÁÆЧµÄMeta·ÖÎö¼°ÊÔÑéÐò¹á·ÖÎö(2)
KEYWORDS Polycystic ovarian syndrome; Chemical medicine; Compound xuanju capsule; Therapeutic efficacy; Meta- analysis; Trial sequential analysis¶àÄÒÂѳ²×ÛºÏÕ÷(Polycystic ovarian syndrome£¬PCOS)ÊÇÁÙ´²Éϳ£¼ûµÄÄÚ·ÖÃÚϵͳ¼²²¡£¬Ö÷Òª±íÏÖΪÔ¾ʧµ÷¡¢ÐÔ¼¤ËØˮƽÎÉÂҵȣ¬Êǵ¼ÖÂÅ®ÐÔ²»ÔеÄÖØÒªÔÒòÖ®Ò»[1]£¬Á÷Ðв¡Ñ§Êý¾Ý±íÃ÷£¬PCOSµÄ·¢²¡Âʸߴï5%¡«10%[2]£¬²»½öÑÏÖØÓ°Ïì×Å»¼ÕßµÄÉú»îÖÊÁ¿ºÍÉúÖ³¹¦ÄÜ£¬»¹¸øÉç»á´øÀ´Á˾޴óµÄ¾¼Ã¸ºµ£¡£Ä¿Ç°PCOSµÄ·¢Éú»úÖÆÉÐδÃ÷Îú£¬ÁÙ´²ÉÏÖ÷ҪʹÓû¯Ñ§Ò©¶ÔÖ¢ÖÎÁÆ[3]£¬ËäÓÐÒ»¶¨ÁÆЧ£¬µ«ÄÑÒÔ±ÜÃâÒ©Î︱×÷ÓôóºÍ»¼ÕßÒײúÉúÒ©ÎïÒÀÀµÐÔµÈȱµã£¬Òò´ËÖÎÁÆʱÈçºÎʹÓÃ×îС¡¢×ȫµÄ¼ÁÁ¿¶øÌá¸ßÁÙ´²ÁÆЧ³ÉΪÁÙ´²Ñо¿µÄÈȵ㡣
Ä¿Ç°£¬ÖÐÒ½ÖÐÒ©ÖÎÁÆPCOSÒòÆäÁÆЧȷÇÐÇÒ¸±×÷ÓÃÉÙÖð½¥Êܵ½ÁÙ´²Ò½Ê¦ºÍ»¼ÕߵĹØ×¢ ......
ÄúÏÖÔڲ鿴ÊÇÕªÒªÒ³£¬È«Îij¤ 4070 ×Ö·û¡£